Most BRAFV600E-driven CRCs arise via the so-called serrated pathway that differs from the classical adenoma–carcinoma sequence in which cancers are generated by early arising Wnt-pathway alterations followed by KRAS, SMAD4, and TP53 mutations. Here, TP53 is linked to adenoma.